Lead Reactor Technologies Specialist:	Lead Automatic Identification & Traceability Specialist:

World Drug Manufacturing Summit 2010

Maritim ProArte Hotel, Berlin, Germany
30th November – 2nd December 2010

Increasing innovation and reducing costs across global operations.

World Drug Manufacturing 2010 is the leading event for small molecule and biologic manufacturers. It regularly attracts over 300 industry members from across manufacturing and supply chain disciplines.

The industry is facing increasing pressure to reduce costs, in order to remain competitive against generics. It is therefore more important than ever that companies reduce waste, streamline processes and increase their global presence.

World Drug Manufacturing 2010 will feature case studies from leading companies such as Novartis, Merck & Co, and Johnson & Johnson, addressing these issues.

Programme highlights include:

• Achieving a sustainable cultural change, engaging the shop floor
• Developing a risk based approach to quality management
• Driving growth through end to end supply chain management
• Embedding sustainability into pharmaceutical R&D and manufacturing
• Delivering savings in capital expenditure across global supply chains
• Maximising capacity utilisation through flexible manufacturing
• Extending operational excellence in to contract manufacturing partners

2010 Confirmed Speakers include:
	Tony Pusic Director, Merck Production System (MPS) Lead, European Operations Merck Sharp & Dohme		Conchita Jimenez-Gonzalez Director, Operational Sustainability GSK
	Jean-François Guilland Head, Global IQP (Innovation, Quality, Productivity), Biopharmaceutical Operations Novartis Pharma AG		Ralf Garczorz VP, Value Chain OTC/CHC Johnson & Johnson Consumer Europe